| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 5, 2003
From the Department of Diagnostic and Interventional Radiology (J.B., J.F.D.), University Hospital Essen, and the Research Laboratories of Schering AG (W.E., C.H., H.-J.W.), Berlin, Germany. * To whom correspondence should be addressed. E-mail: joerg.barkhausen{at}uni-essen.de.
Background--The purpose of this study was to visualize atherosclerotic plaques independently of luminal narrowing using T1-weighted contrast-enhanced MRI. Methods and Results--Eight Watanabe heritable hyperlipidemic (WHHL) rabbits, aged 9 to 18 months, and 8 age-matched controls (New Zealand White rabbits) underwent MRI of the aortic arch before and up to 48 hours after injection of 100 µmol/kg Gadofluorine (Schering AG). Additionally, 8 WHHL rabbits were examined with Magnevist (Schering AG). A half-Fourier acquisition single-shot turbo-spin-echo (HASTE) sequence and a T1-weighted inversion-recovery turbo fast, low-angle shot sequence were used for data acquisition. Immediately after the MR examination, the animals were killed, the aorta was stained with Sudan red, and ex vivo imaging of the stained aortic specimens was performed. Additionally, gadolinium concentrations in plaque (Sudan-positive) and normal (Sudan-negative) aortic wall segments were measured. Plain MR imaging revealed no plaques in the aortic arch in either animal group. Enhancement occurred in the aortic wall of all WHHL rabbits examined with Gadofluorine but not in the vessel wall of animals examined with Magnevist and the control group. Sudan red staining demonstrated multiple plaques in the aortic arch of all WHHL rabbits. Ex vivo imaging demonstrated that the area of hyperenhancement matched the area of plaques stained with Sudan red. The gadolinium concentration was 7±5 nmol/g for normal aortic wall of the control group and 368±30 nmol/g for aortic wall with plaque in WHHL. Conclusions--Gadofluorine enhances the imaging of atherosclerotic plaques and enables improved plaque detection of even nonstenotic lesions that are not visible on unenhanced MRI.
Accepted on March 28, 2003
Detection of Atherosclerotic Plaque With Gadofluorine-Enhanced Magnetic Resonance Imaging
Jörg Barkhausen MD*,
This article has been cited by other articles:
![]() |
E. D. Adler, A. Bystrup, K. C. Briley-Saebo, V. Mani, W. Young, S. Giovanonne, P. Altman, S. J. Kattman, J. A. Frank, H. J. Weinmann, et al. In Vivo Detection of Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells Using Cy3-Labeled Gadofluorine M in Murine Myocardium J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1114 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sirol, P. R. Moreno, K.-R. Purushothaman, E. Vucic, V. Amirbekian, H.-J. Weinmann, P. Muntner, V. Fuster, and Z. A. Fayad Increased Neovascularization in Advanced Lipid-Rich Atherosclerotic Lesions Detected by Gadofluorine-M-Enhanced MRI: Implications for Plaque Vulnerability Circ Cardiovasc Imaging, September 1, 2009; 2(5): 391 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ronald, Y. Chen, A. J.-L. Belisle, A. M. Hamilton, K. A. Rogers, R. A. Hegele, B. Misselwitz, and B. K. Rutt Comparison of Gadofluorine-M and Gd-DTPA for Noninvasive Staging of Atherosclerotic Plaque Stability Using MRI Circ Cardiovasc Imaging, May 1, 2009; 2(3): 226 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. I. Lobbes, R.-J. J. H. M. Miserus, S. Heeneman, V. Lima Passos, P. H. A. Mutsaers, N. Debernardi, B. Misselwitz, M. Post, M. J. A. P. Daemen, J. M. A. van Engelshoven, et al. Atherosclerosis: Contrast-enhanced MR Imaging of Vessel Wall in Rabbit Model--Comparison of Gadofosveset and Gadopentetate Dimeglumine Radiology, March 1, 2009; 250(3): 682 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bendszus, G. Ladewig, L. Jestaedt, B. Misselwitz, L. Solymosi, K. Toyka, and G. Stoll Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study Brain, September 1, 2008; 131(9): 2341 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Harloff, P Dudler, A Frydrychowicz, C Strecker, A L Stroh, A Geibel, C Weiller, A Hetzel, J Hennig, and M Markl Reliability of aortic MRI at 3 Tesla in patients with acute cryptogenic stroke J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 540 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Sosnovik, M. Nahrendorf, and R. Weissleder Molecular Magnetic Resonance Imaging in Cardiovascular Medicine Circulation, April 17, 2007; 115(15): 2076 - 2086. [Full Text] [PDF] |
||||
![]() |
D. Maintz, M. Ozgun, A. Hoffmeier, R. Fischbach, W. Y. Kim, M. Stuber, W. J. Manning, W. Heindel, and R. M. Botnar Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI Eur. Heart J., July 2, 2006; 27(14): 1732 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Wilensky, H. K. Song, and V. A. Ferrari Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C48 - C56. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Desai, J. H. Stone, T. K. F. Foo, D. B. Hellmann, J. A. C. Lima, and D. A. Bluemke Delayed Contrast-Enhanced MRI of the Aortic Wall in Takayasu's Arteritis: Initial Experience Am. J. Roentgenol., May 1, 2005; 184(5): 1427 - 1431. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. McAteer, J. E. Schneider, K. Clarke, S. Neubauer, K. M. Channon, and R. P. Choudhury Quantification and 3D Reconstruction of Atherosclerotic Plaque Components in Apolipoprotein E Knockout Mice Using Ex Vivo High-Resolution MRI Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2384 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sirol, V. V. Itskovich, V. Mani, J. G. S. Aguinaldo, J. T. Fallon, B. Misselwitz, H.-J. Weinmann, V. Fuster, J.-F. Toussaint, and Z. A. Fayad Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging Circulation, June 15, 2004; 109(23): 2890 - 2896. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |